Jul 28
|
Genentech and Roche Present New Insights in Alzheimer’s Disease Research Across Its Diagnostics and Pharmaceutical Portfolios at AAIC
|
Jul 28
|
Roche presents new insights in Alzheimer’s disease research across its diagnostics and pharmaceutical portfolios at AAIC
|
Jul 25
|
Sarepta Therapeutics Provides Clarifying Statement on ELEVIDYS
|
Jul 25
|
Sarepta Therapeutics' Brutal Week Continues With Bad News Out Of Europe
|
Jul 25
|
RXRX vs. RLAY: Which Precision Biotech Stock is a Better Bet Now?
|
Jul 25
|
Sarepta Therapeutics Acknowledges CHMP Negative Opinion for ELEVIDYS in the European Union
|
Jul 25
|
Sarepta stock falls after Elevidys fails to get backing by EU regulators
|
Jul 25
|
Roche provides regulatory update on Elevidys™ gene therapy for Duchenne muscular dystrophy in the EU
|
Jul 25
|
Sarepta woes mount as Duchenne gene therapy knocked back in Europe
|
Jul 25
|
U.S. Diagnostics Market Review 2020-2024 and Outlook to 2030 - Technological Advancements Lower Costs of Molecular Diagnostics, Reshape U.S. Healthcare Landscape
|
Jul 24
|
Europe’s Pharma Stocks Look Cheap but Tariffs Cloud the Outlook
|
Jul 24
|
Roche Reports 7% 1H25 Sales Growth, Key Drugs Perform Well
|
Jul 24
|
Selective Estrogen Receptor Degrader (SERDs) Market Research Report 2025-2030 Featuring AstraZeneca, Eli Lilly, EnhancedBio, Olema Oncology, Radius Therapeutics, and Roche
|
Jul 24
|
Roche Diagnostics showcases science-driven leadership and innovation at ADLM 2025
|
Jul 24
|
Behcet's Disease Market Research Report 2025-2035 | Key Trends, Regulatory Framework, Epidemiology, Clinical Trial Analysis, Market Dynamics
|
Jul 24
|
Health Care Roundup: Market Talk
|
Jul 24
|
Diffuse Large B-cell Lymphoma Market Research Report 2025-2035 | Personalized Medicine and Precision Treatment Trends in DLBCL
|
Jul 24
|
Pharma giant Roche sees income soar in first half
|
Jul 24
|
Roche boss says ‘very easy’ to cut US drug prices by 50%
|
Jul 24
|
Roche Backs 2025 Views After Strong Sales of Key Drugs
|